NIH

For breast cancer prevention, a new study provides evidence for lifestyle modification to reduce weight gain in adults. Read More

New discoveries will guide efforts to develop vaccines or antiviral agents for norovirus, the most common cause of infectious diarrhea. Read More

Too much dietary zinc increases susceptibility to infection by Clostridium difficile — “C. diff” — the most common cause of hospital-acquired infections. Read More

Traditional healers in sub-Saharan have a high rate of exposure to blood, putting them at risk for HIV and hepatitis C. Read More

Vanderbilt University Medical (VUMC) researchers have received a $2.9 million federal grant to test the effectiveness of a new intervention that aims to help older patients reduce the number of medications they may be taking on a regular basis. Read More

Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients. Read More

High levels of blood markers for vascular endothelial dysfunction were associated with longer periods of confusion in ICU patients, Vanderbilt researchers have discovered. Read More

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers. Read More

A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target. Read More

Researchers at Vanderbilt University Medical Center and Vanderbilt University have received a $1.9 million grant from the National Institutes of Health (NIH) to support research to restore vision through regeneration of the retina. Read More

The sphere-forming frequency of neuroblastoma cells is a measure of their proliferative capacity and could help guide treatment strategies for neuroblastoma. Read More

Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease. Read More

Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers. Read More

Vanderbilt University Medical Center (VUMC) has received a five-year, $2 million award from the National Institutes of Health (NIH) to establish the Vanderbilt Emergency Care Research Training Program. Read More

Children with Prader-Willi Syndrome who received growth hormone treatment had cognitive advantages compared to untreated patients. Read More

A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies. Read More

Vanderbilt researchers have discovered that regulation of cell volume plays a role in nerve degeneration and peripheral neuropathies. Read More

The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine. Read More

Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system. Read More

Dario Englot, M.D., Ph.D., has received a grant from the National Institutes of Health to support his research into better understanding brain connectivity disturbances in patients with focal epilepsy. Read More